{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:57:04Z","timestamp":1789945024886,"version":"4.0.1"},"reference-count":29,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2003,7,3]],"date-time":"2003-07-03T00:00:00Z","timestamp":1057190400000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2003,7]]},"abstract":"<jats:p>\n                    <jats:bold>OBJECTIVES:<\/jats:bold>\n                    To assess the relationship between donepezil treatment and time to nursing home placement (NHP) for patients with Alzheimer's disease (AD).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>DESIGN:<\/jats:bold>\n                    Observational follow\u2010up of patient NHP and vital status.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>SETTING:<\/jats:bold>\n                    Community.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>PARTICIPANTS:<\/jats:bold>\n                    Patients previously enrolled in one of three randomized, double\u2010blind, placebo\u2010controlled clinical trials of donepezil and two subsequent open\u2010label studies (total N = 1,115); 671 patients provided complete data for analysis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>MEASUREMENTS:<\/jats:bold>\n                    Data were obtained through follow\u2010up interviews with caregivers and chart reviews of patients with AD. Comparison groups were defined by whether patients received an effective dose of donepezil (\u22655 mg\/d; \u226580% compliance) for specific numbers of weeks during the double\u2010blind or open\u2010label trial phase, in both phases, or in neither. Cox proportional hazards models were used to estimate risk ratios for NHP and survival curves from which median times to NHP were estimated for first dementia\u2010related placement of longer than 2 weeks and permanent placement. The models were adjusted for age, sex, baseline Mini\u2010Mental State Examination score, whether the caregiver was a spouse, caregiver continuity, and use of other cholinesterase inhibitors after the clinical trials.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>RESULTS:<\/jats:bold>\n                    Use of donepezil of 5 mg\/d or more was associated with significant delays in NHP. A cumulative dose\u2010response relationship was observed between longer\u2010term sustained donepezil use and delay of NHP. When donepezil was taken at an effective dose for at least 9 to 12 months, conservative estimates of the time gained before NHP were 21.4 months for first dementia\u2010related NHP and 17.5 months for permanent NHP.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>CONCLUSION:<\/jats:bold>\n                    Use of donepezil by AD patients resulted in significant delays in NHP. Long\u2010term use of donepezil may help AD patients live longer in community settings, with consequent personal, social, and economic benefits.\n                  <\/jats:p>","DOI":"10.1046\/j.1365-2389.2003.51306.x","type":"journal-article","created":{"date-parts":[[2003,9,4]],"date-time":"2003-09-04T07:15:45Z","timestamp":1062659745000},"page":"937-944","source":"Crossref","is-referenced-by-count":222,"title":["Donepezil Is Associated with Delayed Nursing Home Placement in Patients with Alzheimer's Disease"],"prefix":"10.1111","volume":"51","author":[{"given":"David S.","family":"Geldmacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Provenzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"McRae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Mastey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Ieni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,7,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.8.1451"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-199911002-00003"},{"issue":"4","key":"e_1_2_6_4_2","first-page":"S35","article-title":"Behavior and caregiver burden: Behavioral problems in patients with Alzheimer disease and its association with caregiver distress.","volume":"11","author":"Teri L","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1166(1998100)13:10<682::AID-GPS847>3.0.CO;2-Y"},{"key":"e_1_2_6_6_2","first-page":"1304","article-title":"Predictors of time to institutionalization of patients with Alzheimer's disease.","volume":"48","author":"Heyman A","year":"1997","journal-title":"The CERAD Experience, Part XVII. Neurology"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1994.tb04949.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/26.3.267"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/33.6.714"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1988.tb01778.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.147.8.1049"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/31.3.371"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1001\/jama.1996.03540210033030","article-title":"A family intervention to delay nursing home placement of patients with Alzheimer disease: A randomized controlled trial.","volume":"276","author":"Mittelman MS","year":"1996","journal-title":"JAMA"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.7.1008"},{"issue":"6","key":"e_1_2_6_15_2","first-page":"135","article-title":"Economic research on Alzheimer disease. A review of the literature.","volume":"11","author":"Ernst RL","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.17.6.206"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200018030-00002"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/089198879901200107"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000106895"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.9.1021"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.1.136"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.1.166"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(00)00067-5"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.58.3.427"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.3.481"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.3.489"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.4.613"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.72.3.310"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.9.1154"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1532-5415.2002.50005.x"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2389.2003.51306.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2389.2003.51306.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T18:57:45Z","timestamp":1762196265000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2389.2003.51306.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["10.1046\/j.1365-2389.2003.51306.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2389.2003.51306.x","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7]]}}}